Rationale and Design of the Randomized ‘Early Ventricular Assist Device’—Trial (VAD-DZHK3)
The VAD-DZHK3 trial will provide guidance on the optimal timing and patient selection for LVAD implantation in heart transplant candidates, potentially redefining current standards of care.
Authors
- Gerd Hasenfuß (ORCID: https://orcid.org/0000-0002-5942-361X)
- Marius Placzek (ORCID: https://orcid.org/0000-0002-8663-5378)
- Volkmar Falk (ORCID: https://orcid.org/0000-0002-7911-8620)
- Wolfgang Albert
- Andreas Rieth (ORCID: https://orcid.org/0000-0001-8944-1192)
- Tim Friede (ORCID: https://orcid.org/0000-0001-5347-7441)
- Christoph Knosalla (ORCID: https://orcid.org/0000-0002-8127-5019)
- Gloria Färber (ORCID: https://orcid.org/0000-0002-2153-2458)
- Rolf Wachter (ORCID: https://orcid.org/0000-0003-2231-2200)
Institutions
- ETH Zurich (CH)
- Humboldt-Universität zu Berlin (DE)
- Deutsches Herzzentrum der Charité (DE)
- Universitätsmedizin Göttingen (DE)
- University Hospital Leipzig (DE)
- German Centre for Cardiovascular Research (DE)
- Kerckhoff Klinik (DE)
- Jena University Hospital (DE)
- Freie Universität Berlin (DE)
- Friedrich Schiller University Jena (DE)
- Charité - Universitätsmedizin Berlin (DE)
- Saarland University (DE)
Publication Details
- Journal
- ESC Heart Failure
- Published
- 2025-07-20
- DOI
- https://doi.org/10.1002/ehf2.15376
- Citations
- 1
- Primary Topic
- Mechanical Circulatory Support Devices
- Type
- article
- Field-Weighted Citation Impact
- 0.67
Funders
- Deutsches Zentrum für Herz-Kreislaufforschung